4314 -- A Comparison of R-22, R-134a, R-410a, and R-407c Condensation Performance in Smooth and Enhanced Tubes: Part II, Pressure Drop (same as SE-99-4-4) PDF

4314 -- A Comparison of R-22, R-134a, R-410a, and R-407c Condensation Performance in Smooth and Enhanced Tubes: Part II, Pressure Drop (same as SE-99-4-4) PDF

Name:
4314 -- A Comparison of R-22, R-134a, R-410a, and R-407c Condensation Performance in Smooth and Enhanced Tubes: Part II, Pressure Drop (same as SE-99-4-4) PDF

Published Date:
1999

Status:
Active

Description:

Publisher:
ASHRAE

Document status:
Active

Format:
Electronic (PDF)

Delivery time:
10 minutes

Delivery time (for Russian version):
200 business days

SKU:

Choose Document Language:
$4.8
Need Help?

This paper reports pressure drops during condensation for R-22, R-134a, R-410a, and R-407c in three enhanced tubes and one smooth tube. The test tubes were a 3/8 inch outer diameter smooth tube, a 3/8 inch outer diameter microfin tube, a 5/16 inch outer diameter microfin tube, and a 5/8 inch outer diameter microfin tube. Pressure drops are reported at four mass fluxes, at two saturation temperatures, and over a range of average qualities in the test tubes. The pressure drops for R-410a were approximately 40% lower than those of R-22 in both tubes. R-407c had 10% to 20% lower pressure drops than R-22, while R-134a had slightly larger pressure drops than R-22. The microfin tube pressure drops were, on average, 40% to 80% higher than those for the smooth tube for all refrigerants. The pressure drop penalty of the microfin tube was shown to decrease with increased quality.


File Size : 1 file , 380 KB
Note : This product is unavailable in Russia, Belarus
Product Code(s) : D-SE994314
Published : 1999

History


Related products


Best-Selling Products

Alzheimer's Disease Report
Published Date: 12/01/2018
$2398.5
Cystic Fibrosis Disease Report
Published Date: 04/01/2019
$2398.5
Multiple Sclerosis Disease Report
Published Date: 12/01/2018
$2398.5
Non-Alcoholic Steatohepatitis Disease Report
Published Date: 12/01/2018
$2398.5
Non-Hodgkin's Lymphoma Disease Report
Published Date: 12/01/2018
$2398.5